{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:31:55Z","timestamp":1792621915466,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Background: Immunoglobulin M (IgM) nephropathy is an idiopathic glomerulonephritis characterized by diffuse mesangial deposition of IgM. IgM nephropathy has been a controversial diagnosis since it was first reported, and there are few data identifying specific pathological features that predict the risk of progression of renal disease.<\/jats:p>\n                  <jats:p>Methods: We identified 57 cases of IgM nephropathy among 3220 adults undergoing renal biopsy at our institution. Biopsies had to satisfy the following three criteria to meet the definition of IgM nephropathy in this study: (i) dominant mesangial staining for IgM, (ii) mesangial deposits on electron microscopy (EM) and (iii) exclusion of systemic disease.<\/jats:p>\n                  <jats:p>Results: The median age was 42 years and 24 patients were male. Thirty-nine per cent of patients presented with the nephrotic syndrome, 49% presented with non-nephrotic proteinuria and 39% had eGFR &amp;lt;60 mL\/min. The median post-biopsy follow-up was 40 months and serum creatinine had doubled in 31% by 5 years. Of histological parameters, glomerular sclerosis and tubular atrophy, but not mesangial proliferation, were risk factors for renal insufficiency. Thirty-nine per cent of nephrotic patients achieved complete remission, and outcome was significantly worse in those who did not respond to treatment. Focal segmental glomerulosclerosis was diagnosed in 80% of those undergoing repeat renal biopsy, despite ongoing mesangial IgM deposition.<\/jats:p>\n                  <jats:p>Conclusions: We propose criteria for a consensus definition of IgM nephropathy.<\/jats:p>","DOI":"10.1093\/ndt\/gfw063","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T20:33:55Z","timestamp":1460752435000},"page":"823-829","source":"Crossref","is-referenced-by-count":16,"title":["The natural history of immunoglobulin M nephropathy in adults"],"prefix":"10.1093","volume":"32","author":[{"given":"Thomas M.","family":"Connor","sequence":"first","affiliation":[{"name":"1Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, London W12 0NN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Aiello","sequence":"additional","affiliation":[{"name":"2Department of Nephrology, Policlinico S.Orsola-Malpighi, Universit\u00e0 di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Griffith","sequence":"additional","affiliation":[{"name":"1Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, London W12 0NN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cairns","sequence":"additional","affiliation":[{"name":"1Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, London W12 0NN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice A.","family":"Roufosse","sequence":"additional","affiliation":[{"name":"1Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, London W12 0NN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[{"name":"3Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Pusey","sequence":"additional","affiliation":[{"name":"1Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, London W12 0NN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"2025102312493315500_gfw063C1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM197405232902104","article-title":"Recurrent or persistent hematuria. Sign of mesangial immune-complex deposition","volume":"290","author":"Van de Putte","year":"1974","journal-title":"N Engl J Med"},{"key":"2025102312493315500_gfw063C2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9343(79)90741-1","article-title":"Benign primary hematuria. Clinicopathologic study of 65 patients","volume":"67","author":"Pardo","year":"1979","journal-title":"Am J Med"},{"key":"2025102312493315500_gfw063C3","first-page":"610","article-title":"Nephrotic syndrome with glomerular mesangial IgM deposits","volume":"38","author":"Cohen","year":"1978","journal-title":"Lab Invest"},{"key":"2025102312493315500_gfw063C4","first-page":"21","article-title":"Mesangial proliferative glomerulonephritis","volume":"39","author":"Bhasin","year":"1978","journal-title":"Lab Invest"},{"key":"2025102312493315500_gfw063C5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000182598","article-title":"IgM-associated glomerulonephritis","volume":"31","author":"Helin","year":"1982","journal-title":"Nephron"},{"key":"2025102312493315500_gfw063C6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ki.1988.197","article-title":"Distinguishing minimal-change disease from mesangial disorders","volume":"34","author":"Border","year":"1988","journal-title":"Kidney Int"},{"key":"2025102312493315500_gfw063C7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000182071","article-title":"Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits","volume":"27","author":"Cavallo","year":"1981","journal-title":"Nephron"},{"key":"2025102312493315500_gfw063C8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2559.1984.tb02355.x","article-title":"Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases","volume":"8","author":"Hsu","year":"1984","journal-title":"Histopathology"},{"key":"2025102312493315500_gfw063C9","first-page":"230","article-title":"Mesangial deposits of IgM in patients with the nephrotic syndrome","volume":"16","author":"Mampaso","year":"1981","journal-title":"Clin Nephrol"},{"key":"2025102312493315500_gfw063C10","first-page":"395","article-title":"Circulating heavy IgM in IgM nephropathy","volume":"73","author":"Disciullo","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"2025102312493315500_gfw063C11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000183575","article-title":"Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions","volume":"41","author":"Tejani","year":"1985","journal-title":"Nephron"},{"key":"2025102312493315500_gfw063C12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00467-009-1130-0","article-title":"Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome","volume":"24","author":"Swartz","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"2025102312493315500_gfw063C13","first-page":"333","article-title":"IgM-associated primary diffuse mesangial proliferative glomerulonephritis: natural history and prognostic indicators","volume":"79","author":"O'Donoghue","year":"1991","journal-title":"Q J Med"},{"key":"2025102312493315500_gfw063C14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1442-200x.2001.01396.x","article-title":"Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children","volume":"43","author":"Zeis","year":"2001","journal-title":"Pediatr Int"},{"key":"2025102312493315500_gfw063C15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/ajkd.2003.50042","article-title":"IgM nephropathy: clinical picture and long-term prognosis","volume":"41","author":"Myllymaki","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2025102312493315500_gfw063C16","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/ndt\/gfh434","article-title":"Recurrence of IgM nephropathy in a renal allograft","volume":"19","author":"Salmon","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312493315500_gfw063C17","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.transproceed.2006.07.034","article-title":"Early recurrence of nephrotic syndrome (immunoglobulin M nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab","volume":"38","author":"Westphal","year":"2006","journal-title":"Transplant Proc"},{"key":"2025102312493315500_gfw063C18","first-page":"10","article-title":"Significance of mesangial IgM deposition in \u2018minimal change\u2019 nephrotic syndrome","volume":"46","author":"Vilches","year":"1982","journal-title":"Lab Invest"},{"key":"2025102312493315500_gfw063C19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.1984.14","article-title":"No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome","volume":"25","author":"Ji-Yun","year":"1984","journal-title":"Kidney Int"},{"key":"2025102312493315500_gfw063C20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"2025102312493315500_gfw063C21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"2025102312493315500_gfw063C22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0272-6386(85)80150-5","article-title":"C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome","volume":"6","author":"Jennette","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"2025102312493315500_gfw063C23","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00467-009-1429-x","article-title":"C1q nephropathy in the pediatric population: pathology and pathogenesis","volume":"25","author":"Wenderfer","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"2025102312493315500_gfw063C24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0090-1229(83)90069-7","article-title":"Role of immunoglobulin class in mediation of experimental mesangial glomerulonephritis","volume":"27","author":"Border","year":"1983","journal-title":"Clin Immunol Immunopathol"},{"key":"2025102312493315500_gfw063C25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1053\/j.ajkd.2008.10.038","article-title":"Resolution of IgM nephropathy after rituximab treatment","volume":"53","author":"Betjes","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2025102312493315500_gfw063C26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-pathol-011110-130216","article-title":"IgA nephropathy: molecular mechanisms of the disease","volume":"8","author":"Mestecky","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"2025102312493315500_gfw063C27","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"2025102312493315500_gfw063C28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5812\/numonthly.2805","article-title":"IgM nephropathy revisited","volume":"4","author":"Mubarak","year":"2012","journal-title":"Nephrourol Mon"},{"key":"2025102312493315500_gfw063C29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1081\/JDI-100100886","article-title":"Mesangioproliferative glomerulonephritis with IgM deposition: clinical characteristics and outcome","volume":"22","author":"Little","year":"2000","journal-title":"Ren Fail"},{"key":"2025102312493315500_gfw063C30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0377-4929.77315","article-title":"Immunoglobulin M nephropathy in adults and adolescents in India: a single-center study of natural history","volume":"54","author":"Singhai","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"key":"2025102312493315500_gfw063C31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12098-012-0816-7","article-title":"IgM nephropathy","volume":"80","author":"Mubarak","year":"2013","journal-title":"Indian J Pediatr"},{"key":"2025102312493315500_gfw063C32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000167950","article-title":"Clinical follow-up of 54 patients with IgM-nephropathy","volume":"9","author":"Saha","year":"1989","journal-title":"Am J Nephrol"},{"key":"2025102312493315500_gfw063C33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility","volume":"76","author":"Roberts","year":"2009","journal-title":"Kidney Int"},{"key":"2025102312493315500_gfw063C34","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2215\/CJN.02300312","article-title":"A position paper on standardizing the nonneoplastic kidney biopsy report","volume":"7","author":"Chang","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312493315500_gfw063C35","first-page":"1","article-title":"Mayo Clinic\/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN","volume":"27","author":"Sethi","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2025102312493315500_gfw063C36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jcp.33.11.1029","article-title":"IgM associated primary diffuse mesangial proliferative glomerulonephritis","volume":"33","author":"Lawler","year":"1980","journal-title":"J Clin Pathol"},{"key":"2025102312493315500_gfw063C37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tig.2003.11.004","article-title":"Collagens, modifying enzymes and their mutations in humans, flies and worms","volume":"20","author":"Myllyharju","year":"2004","journal-title":"Trends Genet"},{"key":"2025102312493315500_gfw063C38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000183289","article-title":"Mesangial proliferative glomerulonephritis with IgM deposits. Clinicopathologic analysis and evidence for morphologic transitions","volume":"38","author":"Hirszel","year":"1984","journal-title":"Nephron"},{"key":"2025102312493315500_gfw063C39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000166982","article-title":"IgM-associated mesangial proliferative glomerulonephritis and focal and segmental hyalinosis with nephrotic syndrome","volume":"5","author":"Aubert","year":"1985","journal-title":"Am J Nephrol"},{"key":"2025102312493315500_gfw063C40","first-page":"53","article-title":"Incidence and significance of IgM mesangial deposits in relapsing idiopathic nephrotic syndrome of childhood","volume":"86","author":"Bhuyan","year":"1987","journal-title":"Indian J Med Res"},{"key":"2025102312493315500_gfw063C41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000183591","article-title":"Clinical significance of IgM mesangial deposits in the nephrotic syndrome","volume":"41","author":"Gonzalo","year":"1985","journal-title":"Nephron"},{"key":"2025102312493315500_gfw063C42","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2012040389","article-title":"Treatment of primary FSGS in adults","volume":"23","author":"Korbet","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"(Suppl 3)","key":"2025102312493315500_gfw063C43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ndt\/14.suppl_3.68","article-title":"Clinical picture and outcome of primary focal segmental glomerulosclerosis","volume":"14","author":"Korbet","year":"1999","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/32\/5\/823\/24363596\/gfw063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/32\/5\/823\/24363596\/gfw063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:50:28Z","timestamp":1761238228000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/32\/5\/823\/3059414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,4,15]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfw063","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5]]},"published":{"date-parts":[[2016,4,15]]}}}